We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Telstar Promotes Latest Generation of Freeze Dryers in Dubai

By LabMedica International staff writers
Posted on 31 Jan 2019
Print article
Image: The LyoQuest bench-top laboratory freeze dryer (Photo courtesy of Telstar).
Image: The LyoQuest bench-top laboratory freeze dryer (Photo courtesy of Telstar).
Telstar (Shanghai, China) displayed the latest generation of compact laboratory freeze dryers at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. The event saw more than 19,610 unique visitors and 678+ exhibitors sharing the most recent technology available in the IVD, and medical laboratory market.

Among its products exhibited at MedLab Middle East 2019 was the Telstar LyoQuest, a bench-top laboratory freeze dryer that combines this breadth of functionality into a single unit so that users can perform complete cycles on a range of sample containers (vials, trays, ampoules, and flasks) using the same piece of equipment. LyoQuest also enables users to create recipes comprising time, temperature and vacuum control via its integrated PLC control system. Its innovative design results in an extremely compact unit with large condensation capacity up to eight liters and enables many product formats to be pre-frozen by the device, without the need for an additional freezer. The LyoQuest’s ice condenser includes an automatic defrosting function for quick and easy de-icing.

The company also promoted the Telstar Bio II Advance Plus compact range of microbiological safety cabinets (MSC) that are intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3. Their innovative cabinet design offers smaller body than the market average while maintaining standard workspace. With dimensions of 759 mm in width and 1260 mm in height, the Bio II Advance Plus provides a working volume of 340 dm3. Equipped to achieve maximum efficiency, this new range of MSC integrates energy saving EC fans and LED illumination that ensures optimum protection levels as well as low energy consumption. Bio II Advance Plus is designed in compliance with the European standards EN 12469 and certified by TÜV-Nord.

Telstar also displayed Boreas, a new -86º ultra-low-temperature freezer designed to increase average performance by 20% and featuring an innovative mechanical design that enhances robustness, efficiency and ergonomics as well as ensures the integrity of the cold preservation process. Equipped with vacuum panels VIP, the freezer guarantees the highest level of thermal insulation and a temperature of -80ºC under an ambient up to +28ºC. Unlike standard freezers designed with panels based on polyurethane foam, a thinner inner insulation provides Boreas with an enlarged storage capacity of up to 30%. Boreas uses high purity natural refrigerant gases to contribute to environment preservation and does not damage the ozone layer. The ecological ultra-low-freezers line has been developed using Telstar’s in-house cold storage technology.

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.